Senseonics Holdings (SENS) Total Non-Current Liabilities (2014 - 2025)
Senseonics Holdings (SENS) posted quarterly Total Non-Current Liabilities of $61.8 million for Q3 2025, up 61.67% year-over-year from $38.2 million in Q3 2024, and up 11.17% quarter-over-quarter from $55.6 million in Q2 2025.
Senseonics Holdings (SENS) Total Non-Current Liabilities (2014 - 2025) Analysis & Trends
Senseonics Holdings (SENS) has reported Total Non-Current Liabilities for 12 consecutive years, with $61.8 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Total Non-Current Liabilities rose 61.67% year-over-year to $61.8 million; the TTM figure through Sep 2025 stood at $61.8 million (up 61.67% YoY), while the FY2024 annual figure was $41.7 million, down 35.54% from the prior year.
- Total Non-Current Liabilities grew to $61.8 million in Q3 2025 per SENS's latest filing, from $55.6 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $485.5 million in Q3 2021 and bottomed at $38.2 million in Q3 2024.
- Historically, Total Non-Current Liabilities has averaged $139.6 million across 5 years, with a median of $64.7 million in 2023.
- Annual changes were most pronounced in 2021 — Total Non-Current Liabilities jumped 414.57% — and 2023, when it plunged 80.4%.
- Senseonics Holdings' Total Non-Current Liabilities stood at $315.1 million in 2021, then slumped by 66.69% to $104.9 million in 2022, then sank by 38.38% to $64.7 million in 2023, then sank by 35.54% to $41.7 million in 2024, then jumped by 48.17% to $61.8 million in 2025.
- Business Quant data shows SENS's Total Non-Current Liabilities at $61.8 million in Q3 2025, $55.6 million in Q2 2025, and $46.3 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Senseonics Holdings | 560.79 Mn | 320.18 Mn | 8.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 61.76 Mn |
| Jun 30, 2025 | 55.55 Mn |
| Mar 31, 2025 | 46.35 Mn |
| Dec 31, 2024 | 41.68 Mn |
| Sep 30, 2024 | 38.20 Mn |
| Jun 30, 2024 | 67.32 Mn |
| Mar 31, 2024 | 63.78 Mn |
| Dec 31, 2023 | 64.67 Mn |
| Sep 30, 2023 | 58.03 Mn |
| Jun 30, 2023 | 56.76 Mn |
| Mar 31, 2023 | 54.33 Mn |
| Dec 31, 2022 | 104.94 Mn |
| Sep 30, 2022 | 194.88 Mn |
| Jun 30, 2022 | 104.65 Mn |
| Mar 31, 2022 | 277.23 Mn |
| Dec 31, 2021 | 315.06 Mn |
| Sep 30, 2021 | 485.45 Mn |
| Jun 30, 2021 | 180.39 Mn |
| Mar 31, 2021 | 380.58 Mn |
| Dec 31, 2020 | 115.07 Mn |